Literature DB >> 11443533

Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene.

H Kunugi1, S Ishida, A Akahane, S Nanko.   

Abstract

The synaptic vesicular monoamine transporter (SVMT), alternatively vesicular monoamine transporter 2 (VMAT2), pumps cytosolic monoamines including dopamine, norepinephrine, serotonin, and histamine into synaptic vesicles. Altered functions of SVMT have been implicated in the pathogensis of several neuropsychiatric diseases. We determined exon/intron boundaries of the human SVMT gene and performed mutational analysis for the exonic and neighboring intronic regions of the gene. Detected polymorphisms were subject to association analysis with schizophrenia in a family-based design. The human SVMT gene consists, of 16 exons and 15 introns, which is consistent with the murine SVMT gene. When mutational analysis was performed by the single strand conformational polymorphism (SSCP) analysis, we found two and four single nucleotide polymorphisms (SNPs) in exons and neighboring introns, respectively. Neither exonic SNP results in an amino acid change. In family-based association analyses in a sample of 50 Japanese schizophrenics and their parents, no significant association was found for the intronic polymorphisms. Our data suggest that there is no common polymorphism in the SVMT gene affecting the primary structure of the human SVMT protein. Furthermore, we obtained no evidence for the major effect of the novel polymorphisms on susceptibility to schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443533     DOI: 10.1038/sj.mp.4000895

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  8 in total

1.  Intermediate phenotype analysis of patients, unaffected siblings, and healthy controls identifies VMAT2 as a candidate gene for psychotic disorder and neurocognition.

Authors:  Claudia J P Simons; Ruud van Winkel
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

2.  Experimenting with spirituality: analyzing The God Gene in a nonmajors laboratory course.

Authors:  Linda A Silveira
Journal:  CBE Life Sci Educ       Date:  2008       Impact factor: 3.325

3.  Genetic dissection of the Gpnmb network in the eye.

Authors:  Hong Lu; Xusheng Wang; Matthew Pullen; Huaijin Guan; Hui Chen; Shwetapadma Sahu; Bing Zhang; Hao Chen; Robert W Williams; Eldon E Geisert; Lu Lu; Monica M Jablonski
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-13       Impact factor: 4.799

4.  Vmat2 heterozygous mutant mice display a depressive-like phenotype.

Authors:  Masato Fukui; Ramona M Rodriguiz; Jiechun Zhou; Sara X Jiang; Lindsey E Phillips; Marc G Caron; William C Wetsel
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

5.  A network of dopaminergic gene variations implicated as risk factors for schizophrenia.

Authors:  Michael E Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo Torres; Hader Mansour; Kodavali V Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale Prasad; Brian Shirts; Jianping Zhang; Michael C O'Donovan; Michael J Owen; Bernie Devlin; Vishwajit L Nimgaonkar
Journal:  Hum Mol Genet       Date:  2007-11-27       Impact factor: 6.150

Review 6.  Dopamine genes and schizophrenia: case closed or evidence pending?

Authors:  Michael E Talkowski; Mikhil Bamne; Hader Mansour; Vishwajit L Nimgaonkar
Journal:  Schizophr Bull       Date:  2007-07-14       Impact factor: 9.306

7.  Association study of the vesicular monoamine transporter 1 (VMAT1) gene with schizophrenia in a Japanese population.

Authors:  Misty Richards; Yoshimi Iijima; Hitomi Kondo; Tomoko Shizuno; Hiroaki Hori; Kunimasa Arima; Osamu Saitoh; Hiroshi Kunugi
Journal:  Behav Brain Funct       Date:  2006-11-30       Impact factor: 3.759

8.  The effect of alcohol on the differential expression of cluster of differentiation 14 gene, associated pathways, and genetic network.

Authors:  Diana X Zhou; Yinghong Zhao; Jessica A Baker; Qingqing Gu; Kristin M Hamre; Junming Yue; Byron C Jones; Melloni N Cook; Lu Lu
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.